CARBOPLATIN AND GEMCITABINE IN ELDERLY AND/OR FRAIL PATIENTS (PTS) WITH ADVANCED TRANSITIONAL CELL CARCINOMA (TCC): A PHASE II STUDY

被引:0
|
作者
Baitar, A. [1 ]
De Vos, M. [1 ]
Vandebroek, A. [1 ]
Schrijvers, D. [1 ]
机构
[1] ZNA Middelheim, Dept Med Oncol, Antwerp, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:281 / 281
页数:1
相关论文
共 50 条
  • [21] Carboplatin monochemotherapy in elderly patients with nonoperable transitional cell carcinoma of the bladder: A two-stage, phase II study
    Segati, R
    Bari, M
    Azzarello, G
    Signorelli, C
    Marchini, M
    Fiaccavento, G
    Longo, M
    Pappagallo, GL
    Vinante, O
    [J]. EUROPEAN UROLOGY, 1996, 29 (03) : 312 - 316
  • [22] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    [J]. CANCER, 2005, 103 (11) : 2298 - 2303
  • [23] Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function
    Helke, C.
    May, M.
    Hoschke, B.
    [J]. AKTUELLE UROLOGIE, 2006, 37 (05) : 363 - 368
  • [24] Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [25] Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract -: An alternative therapy
    Nogué-Aliguer, M
    Carles, J
    Arrivi, A
    Juan, O
    Alonso, L
    Font, A
    Mellado, B
    Garrido, P
    Sáenz, A
    [J]. CANCER, 2003, 97 (09) : 2180 - 2186
  • [26] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
    Smith, David C.
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hussain, Maha
    Wood, David
    Lee, Cheryl T.
    Sanda, Martin
    Vaishampayan, Ulka
    Petrylak, Daniel P.
    Quinn, David I.
    Beekman, Kathleen
    Montie, James E.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (06): : 2384 - 2388
  • [27] Phase I/II study of dose-dense sequential chemotherapy in renal impaired patients (Pts) with transitional cell carcinoma (TCC) of the urothelium.
    Galsky, MD
    Mironov, S
    Scattergood, J
    Dobrzynski, D
    Mitra, N
    Boyle, MG
    Bajorin, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 385S - 385S
  • [28] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [29] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 409S - 409S
  • [30] Multi-institutional phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Sasaki, J.
    Uramoto, H.
    Kashiwabara, K.
    Kishi, H.
    Moriyam, E.
    Ushijima, S.
    Fujii, S.
    Senba, H.
    Okamoto, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)